Literature DB >> 33427645

Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival.

Paul Guilhamon1,2, Charles Chesnelong2, Michelle M Kushida2, Ana Nikolic3,4,5, Divya Singhal3,4,5, Graham MacLeod6, Seyed Ali Madani Tonekaboni1,7, Florence Mg Cavalli2, Christopher Arlidge1, Nishani Rajakulendran6, Naghmeh Rastegar2, Xiaoguang Hao3,8,9, Rozina Hassam3,8,9, Laura J Smith10, Heather Whetstone2, Fiona J Coutinho2, Bettina Nadorp1, Katrina I Ellestad3,4, H Artee Luchman3,8,9, Jennifer Ai-Wen Chan3,4,11, Molly S Shoichet10, Michael D Taylor2,12,13, Benjamin Haibe-Kains1,7,14,15,16, Samuel Weiss3,8,9,17, Stephane Angers6,18, Marco Gallo3,4,5,17, Peter B Dirks2,12,15, Mathieu Lupien1,7.   

Abstract

Chromatin accessibility discriminates stem from mature cell populations, enabling the identification of primitive stem-like cells in primary tumors, such as glioblastoma (GBM) where self-renewing cells driving cancer progression and recurrence are prime targets for therapeutic intervention. We show, using single-cell chromatin accessibility, that primary human GBMs harbor a heterogeneous self-renewing population whose diversity is captured in patient-derived glioblastoma stem cells (GSCs). In-depth characterization of chromatin accessibility in GSCs identifies three GSC states: Reactive, Constructive, and Invasive, each governed by uniquely essential transcription factors and present within GBMs in varying proportions. Orthotopic xenografts reveal that GSC states associate with survival, and identify an invasive GSC signature predictive of low patient survival, in line with the higher invasive properties of Invasive state GSCs compared to Reactive and Constructive GSCs as shown by in vitro and in vivo assays. Our chromatin-driven characterization of GSC states improves prognostic precision and identifies dependencies to guide combination therapies.
© 2021, Guilhamon et al.

Entities:  

Keywords:  ATAC; Glioblastoma; cancer biology; cancer stem cell; chromatin; human; single cell ATAC; tumor initiating cells

Mesh:

Substances:

Year:  2021        PMID: 33427645      PMCID: PMC7847307          DOI: 10.7554/eLife.64090

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  61 in total

1.  An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues.

Authors:  M Ryan Corces; Alexandro E Trevino; Emily G Hamilton; Peyton G Greenside; Nicholas A Sinnott-Armstrong; Sam Vesuna; Ansuman T Satpathy; Adam J Rubin; Kathleen S Montine; Beijing Wu; Arwa Kathiria; Seung Woo Cho; Maxwell R Mumbach; Ava C Carter; Maya Kasowski; Lisa A Orloff; Viviana I Risca; Anshul Kundaje; Paul A Khavari; Thomas J Montine; William J Greenleaf; Howard Y Chang
Journal:  Nat Methods       Date:  2017-08-28       Impact factor: 28.547

2.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

3.  Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.

Authors:  Graham MacLeod; Danielle A Bozek; Nishani Rajakulendran; Vernon Monteiro; Moloud Ahmadi; Zachary Steinhart; Michelle M Kushida; Helen Yu; Fiona J Coutinho; Florence M G Cavalli; Ian Restall; Xiaoguang Hao; Traver Hart; H Artee Luchman; Samuel Weiss; Peter B Dirks; Stephane Angers
Journal:  Cell Rep       Date:  2019-04-16       Impact factor: 9.423

4.  FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.

Authors:  Peng Cheng; Jia Wang; Indrayani Waghmare; Stefania Sartini; Vito Coviello; Zhuo Zhang; Sung-Hak Kim; Ahmed Mohyeldin; Marat S Pavlyukov; Mutsuko Minata; Claudia L L Valentim; Rishi Raj Chhipa; Krishna P L Bhat; Biplab Dasgupta; Concettina La Motta; Madhuri Kango-Singh; Ichiro Nakano
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

5.  Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.

Authors:  Steven M Pollard; Koichi Yoshikawa; Ian D Clarke; Davide Danovi; Stefan Stricker; Roslin Russell; Jane Bayani; Renee Head; Marco Lee; Mark Bernstein; Jeremy A Squire; Austin Smith; Peter Dirks
Journal:  Cell Stem Cell       Date:  2009-06-05       Impact factor: 24.633

6.  Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.

Authors:  Mario L Suvà; Esther Rheinbay; Shawn M Gillespie; Anoop P Patel; Hiroaki Wakimoto; Samuel D Rabkin; Nicolo Riggi; Andrew S Chi; Daniel P Cahill; Brian V Nahed; William T Curry; Robert L Martuza; Miguel N Rivera; Nikki Rossetti; Simon Kasif; Samantha Beik; Sabah Kadri; Itay Tirosh; Ivo Wortman; Alex K Shalek; Orit Rozenblatt-Rosen; Aviv Regev; David N Louis; Bradley E Bernstein
Journal:  Cell       Date:  2014-04-10       Impact factor: 41.582

7.  CONICS integrates scRNA-seq with DNA sequencing to map gene expression to tumor sub-clones.

Authors:  Sören Müller; Ara Cho; Siyuan J Liu; Daniel A Lim; Aaron Diaz
Journal:  Bioinformatics       Date:  2018-09-15       Impact factor: 6.937

8.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.

Authors:  Zefang Tang; Chenwei Li; Boxi Kang; Ge Gao; Cheng Li; Zemin Zhang
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

9.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

10.  g:Profiler-a web server for functional interpretation of gene lists (2016 update).

Authors:  Jüri Reimand; Tambet Arak; Priit Adler; Liis Kolberg; Sulev Reisberg; Hedi Peterson; Jaak Vilo
Journal:  Nucleic Acids Res       Date:  2016-04-20       Impact factor: 16.971

View more
  8 in total

1.  Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states.

Authors:  Ronan Chaligne; Federico Gaiti; Dana Silverbush; Joshua S Schiffman; Hannah R Weisman; Lloyd Kluegel; Simon Gritsch; Sunil D Deochand; L Nicolas Gonzalez Castro; Alyssa R Richman; Johanna Klughammer; Tommaso Biancalani; Christoph Muus; Caroline Sheridan; Alicia Alonso; Franco Izzo; Jane Park; Orit Rozenblatt-Rosen; Aviv Regev; Mario L Suvà; Dan A Landau
Journal:  Nat Genet       Date:  2021-09-30       Impact factor: 38.330

Review 2.  Glial and myeloid heterogeneity in the brain tumour microenvironment.

Authors:  Brian M Andersen; Camilo Faust Akl; Michael A Wheeler; E Antonio Chiocca; David A Reardon; Francisco J Quintana
Journal:  Nat Rev Cancer       Date:  2021-09-28       Impact factor: 69.800

3.  Cancer cell states and emergent properties of the dynamic tumor system.

Authors:  Dalia Barkley; Anjali Rao; Maayan Pour; Gustavo S França; Itai Yanai
Journal:  Genome Res       Date:  2021-10       Impact factor: 9.438

4.  Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survival.

Authors:  Xi Lu; Naga Prathyusha Maturi; Malin Jarvius; Irem Yildirim; Yonglong Dang; Linxuan Zhao; Yuan Xie; E-Jean Tan; Pengwei Xing; Rolf Larsson; Mårten Fryknäs; Lene Uhrbom; Xingqi Chen
Journal:  Nat Commun       Date:  2022-04-25       Impact factor: 17.694

Review 5.  Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma.

Authors:  Yahaya A Yabo; Simone P Niclou; Anna Golebiewska
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

Review 6.  Roles of Chromatin Remodelling and Molecular Heterogeneity in Therapy Resistance in Glioblastoma.

Authors:  Huey-Miin Chen; Ana Nikolic; Divya Singhal; Marco Gallo
Journal:  Cancers (Basel)       Date:  2022-10-09       Impact factor: 6.575

Review 7.  Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities.

Authors:  Amanda L Johnson; John Laterra; Hernando Lopez-Bertoni
Journal:  Front Oncol       Date:  2022-09-21       Impact factor: 5.738

Review 8.  Exploiting Single-Cell Tools in Gene and Cell Therapy.

Authors:  Daniel Bode; Alyssa H Cull; Juan A Rubio-Lara; David G Kent
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.